Oral Vaccine Market Report

Europe Oral Vaccine Market Size, Status and Forecast 2014-2026

  • POSTDATE：Apr 01, 2020
  • PAGES：205
  • REPORT CODE：GMM529061
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Oral Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.4% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Oral Vaccine Market Segmentations:

    By Player:

    • EuBiologics

    • Lanzhou Institute

    • Shanghai United Cell

    • PaxVax

    • Sanofi

    • Halfkin Bio-Pharmaceuticals

    • Bibcol

    • Valneva

    • Vabiotech

    • Merck

    • Tiantan Biological

    • GSK

    • Serum Institute

    • Panacea Biotec Ltd

    • Bio-Med

    By Type:

    • Rotavirus Vaccine

    • Cholera Vaccine

    • Oral Polio Vaccine

    • Others

    By End-User:

    • Public

    • Private

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oral Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Oral Vaccine Market Size and Growth Rate of Rotavirus Vaccine from 2014 to 2026

    • 1.3.2 Europe Oral Vaccine Market Size and Growth Rate of Cholera Vaccine from 2014 to 2026

    • 1.3.3 Europe Oral Vaccine Market Size and Growth Rate of Oral Polio Vaccine from 2014 to 2026

    • 1.3.4 Europe Oral Vaccine Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Oral Vaccine Market Size and Growth Rate of Public from 2014 to 2026

    • 1.4.2 Europe Oral Vaccine Market Size and Growth Rate of Private from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Oral Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Oral Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Oral Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Oral Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Oral Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Oral Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Oral Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Oral Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Oral Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Oral Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oral Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Rotavirus Vaccine

      • 3.4.2 Market Size and Growth Rate of Cholera Vaccine

      • 3.4.3 Market Size and Growth Rate of Oral Polio Vaccine

      • 3.4.4 Market Size and Growth Rate of Others

    4 Segmentation of Oral Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oral Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oral Vaccine for Public

      • 4.4.2 Market Size and Growth Rate of Oral Vaccine for Private

    5 Market Analysis by Major Regions

    • 5.1 Europe Oral Vaccine Production Analysis by Top Regions

    • 5.2 Europe Oral Vaccine Consumption Analysis by Top Regions

    • 5.3 Europe Oral Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Oral Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Oral Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 France Oral Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Oral Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Oral Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Oral Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Oral Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Oral Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Oral Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Oral Vaccine Market among Top Countries

    • 6.1 Top 5 Export Countries in Oral Vaccine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Oral Vaccine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Oral Vaccine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Oral Vaccine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Oral Vaccine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Oral Vaccine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Oral Vaccine Landscape Analysis

    • 7.1 Germany Oral Vaccine Landscape Analysis by Major Types

    • 7.2 Germany Oral Vaccine Landscape Analysis by Major End-Users

    8. UK Oral Vaccine Landscape Analysis

    • 8.1 UK Oral Vaccine Landscape Analysis by Major Types

    • 8.2 UK Oral Vaccine Landscape Analysis by Major End-Users

    9. France Oral Vaccine Landscape Analysis

    • 9.1 France Oral Vaccine Landscape Analysis by Major Types

    • 9.2 France Oral Vaccine Landscape Analysis by Major End-Users

    10. Italy Oral Vaccine Landscape Analysis

    • 10.1 Italy Oral Vaccine Landscape Analysis by Major Types

    • 10.2 Italy Oral Vaccine Landscape Analysis by Major End-Users

    11. Spain Oral Vaccine Landscape Analysis

    • 11.1 Spain Oral Vaccine Landscape Analysis by Major Types

    • 11.2 Spain Oral Vaccine Landscape Analysis by Major End-Users

    12. Poland Oral Vaccine Landscape Analysis

    • 12.1 Poland Oral Vaccine Landscape Analysis by Major Types

    • 12.2 Poland Oral Vaccine Landscape Analysis by Major End-Users

    13. Russia Oral Vaccine Landscape Analysis

    • 13.1 Russia Oral Vaccine Landscape Analysis by Major Types

    • 13.2 Russia Oral Vaccine Landscape Analysis by Major End-Users

    14. Switzerland Oral Vaccine Landscape Analysis

    • 14.1 Switzerland Oral Vaccine Landscape Analysis by Major Types

    • 14.2 Switzerland Oral Vaccine Landscape Analysis by Major End-Users

    15. Turkey Oral Vaccine Landscape Analysis

    • 15.1 Turkey Oral Vaccine Landscape Analysis by Major Types

    • 15.2 Turkey Oral Vaccine Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccine Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccine Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccine Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccine Landscape Analysis by Top Countries

      • 16.3.1 Denmark Oral Vaccine Market Volume and Growth Rate

      • 16.3.2 Finland Oral Vaccine Market Volume and Growth Rate

      • 16.3.3 Norway Oral Vaccine Market Volume and Growth Rate

      • 16.3.4 Sweden Oral Vaccine Market Volume and Growth Rate

      • 16.3.6 Iceland Oral Vaccine Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccine Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccine Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccine Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccine Landscape Analysis by Top Countries

      • 17.3.1 Belgium Oral Vaccine Market Volume and Growth Rate

      • 17.3.2 Netherlands Oral Vaccine Market Volume and Growth Rate

      • 17.3.3 Luxembourg Oral Vaccine Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccine Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccine Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccine Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccine Landscape Analysis by Top Countries

      • 18.3.1 Estonia Oral Vaccine Market Volume and Growth Rate

      • 18.3.2 Latvia Oral Vaccine Market Volume and Growth Rate

      • 18.3.3 Lithuania Oral Vaccine Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 EuBiologics

      • 19.1.1 EuBiologics Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Lanzhou Institute

      • 19.2.1 Lanzhou Institute Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Shanghai United Cell

      • 19.3.1 Shanghai United Cell Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 PaxVax

      • 19.4.1 PaxVax Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Sanofi

      • 19.5.1 Sanofi Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Halfkin Bio-Pharmaceuticals

      • 19.6.1 Halfkin Bio-Pharmaceuticals Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Bibcol

      • 19.7.1 Bibcol Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Valneva

      • 19.8.1 Valneva Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Vabiotech

      • 19.9.1 Vabiotech Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Merck

      • 19.10.1 Merck Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Tiantan Biological

      • 19.11.1 Tiantan Biological Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 GSK

      • 19.12.1 GSK Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Serum Institute

      • 19.13.1 Serum Institute Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Panacea Biotec Ltd

      • 19.14.1 Panacea Biotec Ltd Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Bio-Med

      • 19.15.1 Bio-Med Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    The List of Tables and Figures (Totals 92 Figures and 131 Tables)

    • Figure Product Picture

    • Figure Europe Oral Vaccine Market Size and Growth Rate of Rotavirus Vaccine from 2014 to 2026

    • Figure Europe Oral Vaccine Market Size and Growth Rate of Cholera Vaccine from 2014 to 2026

    • Figure Europe Oral Vaccine Market Size and Growth Rate of Oral Polio Vaccine from 2014 to 2026

    • Figure Europe Oral Vaccine Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Oral Vaccine Market Size and Growth Rate of Public from 2014 to 2026

    • Figure Europe Oral Vaccine Market Size and Growth Rate of Private from 2014 to 2026

    • Figure Germany Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure France Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Oral Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Oral Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Oral Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oral Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Oral Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Rotavirus Vaccine

    • Figure Market Size and Growth Rate of Cholera Vaccine

    • Figure Market Size and Growth Rate of Oral Polio Vaccine

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Oral Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Oral Vaccine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Public

    • Figure Market Size and Growth Rate of Private

    • Table Europe Oral Vaccine Production by Major Regions

    • Table Europe Oral Vaccine Production Share by Major Regions

    • Figure Europe Oral Vaccine Production Share by Major Countries and Regions in 2014

    • Table Europe Oral Vaccine Consumption by Major Regions

    • Table Europe Oral Vaccine Consumption Share by Major Regions

    • Table Germany Oral Vaccine Production, Import, Consumption and Export Analysis

    • Table UK Oral Vaccine Production, Import, Consumption and Export Analysis

    • Table France Oral Vaccine Production, Import, Consumption and Export Analysis

    • Table Italy Oral Vaccine Production, Import, Consumption and Export Analysis

    • Table Spain Oral Vaccine Production, Import, Consumption and Export Analysis

    • Table Poland Oral Vaccine Production, Import, Consumption and Export Analysis

    • Table Russia Oral Vaccine Production, Import, Consumption and Export Analysis

    • Table Switzerland Oral Vaccine Production, Import, Consumption and Export Analysis

    • Table Turkey Oral Vaccine Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccine Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccine Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Oral Vaccine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Oral Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Oral Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Oral Vaccine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Oral Vaccine Consumption by Types from 2014 to 2026

    • Table Germany Oral Vaccine Consumption Share by Types from 2014 to 2026

    • Table Germany Oral Vaccine Consumption by End-Users from 2014 to 2026

    • Table Germany Oral Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table UK Oral Vaccine Consumption by Types from 2014 to 2026

    • Table UK Oral Vaccine Consumption Share by Types from 2014 to 2026

    • Table UK Oral Vaccine Consumption by End-Users from 2014 to 2026

    • Table UK Oral Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table France Oral Vaccine Consumption by Types from 2014 to 2026

    • Table France Oral Vaccine Consumption Share by Types from 2014 to 2026

    • Table France Oral Vaccine Consumption by End-Users from 2014 to 2026

    • Table France Oral Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Italy Oral Vaccine Consumption by Types from 2014 to 2026

    • Table Italy Oral Vaccine Consumption Share by Types from 2014 to 2026

    • Table Italy Oral Vaccine Consumption by End-Users from 2014 to 2026

    • Table Italy Oral Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Spain Oral Vaccine Consumption by Types from 2014 to 2026

    • Table Spain Oral Vaccine Consumption Share by Types from 2014 to 2026

    • Table Spain Oral Vaccine Consumption by End-Users from 2014 to 2026

    • Table Spain Oral Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Poland Oral Vaccine Consumption by Types from 2014 to 2026

    • Table Poland Oral Vaccine Consumption Share by Types from 2014 to 2026

    • Table Poland Oral Vaccine Consumption by End-Users from 2014 to 2026

    • Table Poland Oral Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Russia Oral Vaccine Consumption by Types from 2014 to 2026

    • Table Russia Oral Vaccine Consumption Share by Types from 2014 to 2026

    • Table Russia Oral Vaccine Consumption by End-Users from 2014 to 2026

    • Table Russia Oral Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Oral Vaccine Consumption by Types from 2014 to 2026

    • Table Switzerland Oral Vaccine Consumption Share by Types from 2014 to 2026

    • Table Switzerland Oral Vaccine Consumption by End-Users from 2014 to 2026

    • Table Switzerland Oral Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Oral Vaccine Consumption by Types from 2014 to 2026

    • Table Turkey Oral Vaccine Consumption Share by Types from 2014 to 2026

    • Table Turkey Oral Vaccine Consumption by End-Users from 2014 to 2026

    • Table Turkey Oral Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccine Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccine Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccine Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oral Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Oral Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Oral Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Oral Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Oral Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Oral Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccine Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccine Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccine Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oral Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Oral Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Oral Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Oral Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccine Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccine Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccine Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oral Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Oral Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Oral Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Oral Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of EuBiologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EuBiologics

    • Figure Sales and Growth Rate Analysis of EuBiologics

    • Figure Revenue and Market Share Analysis of EuBiologics

    • Table Product and Service Introduction of EuBiologics

    • Table Company Profile and Development Status of Lanzhou Institute

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lanzhou Institute

    • Figure Sales and Growth Rate Analysis of Lanzhou Institute

    • Figure Revenue and Market Share Analysis of Lanzhou Institute

    • Table Product and Service Introduction of Lanzhou Institute

    • Table Company Profile and Development Status of Shanghai United Cell

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai United Cell

    • Figure Sales and Growth Rate Analysis of Shanghai United Cell

    • Figure Revenue and Market Share Analysis of Shanghai United Cell

    • Table Product and Service Introduction of Shanghai United Cell

    • Table Company Profile and Development Status of PaxVax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PaxVax

    • Figure Sales and Growth Rate Analysis of PaxVax

    • Figure Revenue and Market Share Analysis of PaxVax

    • Table Product and Service Introduction of PaxVax

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Halfkin Bio-Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Halfkin Bio-Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Halfkin Bio-Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Halfkin Bio-Pharmaceuticals

    • Table Product and Service Introduction of Halfkin Bio-Pharmaceuticals

    • Table Company Profile and Development Status of Bibcol

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bibcol

    • Figure Sales and Growth Rate Analysis of Bibcol

    • Figure Revenue and Market Share Analysis of Bibcol

    • Table Product and Service Introduction of Bibcol

    • Table Company Profile and Development Status of Valneva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valneva

    • Figure Sales and Growth Rate Analysis of Valneva

    • Figure Revenue and Market Share Analysis of Valneva

    • Table Product and Service Introduction of Valneva

    • Table Company Profile and Development Status of Vabiotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vabiotech

    • Figure Sales and Growth Rate Analysis of Vabiotech

    • Figure Revenue and Market Share Analysis of Vabiotech

    • Table Product and Service Introduction of Vabiotech

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Tiantan Biological

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tiantan Biological

    • Figure Sales and Growth Rate Analysis of Tiantan Biological

    • Figure Revenue and Market Share Analysis of Tiantan Biological

    • Table Product and Service Introduction of Tiantan Biological

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Serum Institute

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute

    • Figure Sales and Growth Rate Analysis of Serum Institute

    • Figure Revenue and Market Share Analysis of Serum Institute

    • Table Product and Service Introduction of Serum Institute

    • Table Company Profile and Development Status of Panacea Biotec Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Panacea Biotec Ltd

    • Figure Sales and Growth Rate Analysis of Panacea Biotec Ltd

    • Figure Revenue and Market Share Analysis of Panacea Biotec Ltd

    • Table Product and Service Introduction of Panacea Biotec Ltd

    • Table Company Profile and Development Status of Bio-Med

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio-Med

    • Figure Sales and Growth Rate Analysis of Bio-Med

    • Figure Revenue and Market Share Analysis of Bio-Med

    • Table Product and Service Introduction of Bio-Med

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US